Intrathecal Neostigmine for Post-Cesarean Section Analgesia

Authors:
  • JKJames A. Krukowski
    James A. Krukowski
  • DHDavid D. Hood
    David D. Hood
  • JEJames C. Eisenach
    James C. Eisenach
  • KMKathryn A. Mallak
    Kathryn A. Mallak
  • RPR. Lamar Parker
    R. Lamar Parker

Abstract
-epidural anesthetic. Using an open-label, dose-ranging design, patients received either IT placebo or neostigmine 10, 30, or 100 micro g in a 1-mL solution of 5% glucose in normal saline followed in 15 min by 2% epidural lidocaine for cesarean section. Neostigmine did not affect fetal heart rate tracings or Apgar scores. The women received patient-controlled analgesia intravenous morphine postoperatively. Compared with the glucose control, neostigmine produced a dose-independent reduction in postoperative morphine use. Cumulative average 24-h morphine use was 82 +/- 7 mg for women receiving IT placebo and 50 +/- 8 mg for women receiving IT neostigmine (P < 0.003). Hourly morphine use was significantly reduced in the neostigmine groups for 10 h postoperatively. These data indicate that IT neostigmine can produce 10 h of post-cesarean section analgesia without adverse fetal effects and support cautious further prospective study. (Anesth Analg 1997;84:1269-75)...

This publication has 21 references indexed in Scilit: